Connect with us

Breakthroughs

FDA: Peanut Allergy Drug Approved

Published

on

bowls of peanut butter | FDA: Peanut Allergy Drug Approved | Featured
Image via Shutterstock

The U.S. Food and Drug Administration has approved Aimmune Therapeutics’s drug that reduces – and potentially eliminates – kids’ allergic reactions to peanuts. According to Fox Business, the pharmaceutical company’s stock was up more than 20 percent as parents [and] their children from ages 4 to 17 received hope on the FDA action.

The news article explains that the drug “arrests any allergic reactions such as anaphylaxis, that occur after exposure to peanuts.” The company explains that allergy sufferers must still maintain a peanut-free diet. The drug is not intended as an emergency treatment.

CNN explains that it is designed to “minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy.”

Aimmune will market the drug under the brand name Palforzia.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

SIGN UP FOR BNA NEWSLETTERS

Will You Vote For President Trump
Everstryke Match Ad

Copyright © 2022 Breaking News Alerts. This copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.